Nivolumab as maintenance therapy following platinum-based chemotherapy in EGFR-mutant lung cancer patients after tyrosine kinase inhibitor failure: A single-arm, open-label, phase 2 trial

Kim, J; Choi, CM; Ji, W; Lee, JC

Ji, W; Lee, JC (通讯作者),Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.;Lee, JC (通讯作者),Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.

THORACIC CANCER, 2023; 14 (31): 3080

Abstract

Background: As the outcome of immunotherapy can be improved when concurrently or sequentially combined with cytotoxic chemotherapy or radiotherapy, we......

Full Text Link